- ►diabetesjournals.org L Monnier, H Lapinski, C Colette - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In 290 non–insulin- and non–acarbose-using
patients with type 2 diabetes, plasma glucose (PG) concentrations were
determined at fasting (8:00 am.) and during postprandial and postabsorptive ... Cited by 545 - Related articles - BL Direct - All 5 versions
P Raskin, E Allen, P Hollander, A Lewin, RA … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—A total of 209 subjects completed the study. At study end, the mean
HbA 1c value was lower in the BIAsp 70/30 group than in the glargine group (6.91
± 1.17 vs. 7.41 ± 1.24%, P < 0.01). The HbA 1c reduction was greater in ... Cited by 323 - Related articles - All 7 versions
L Monnier, C Colette, L Monnier, C Colette - Endocrine Practice, 2006 - AACE Until recently, the exact contributions of fasting and postprandial glucose to
the overall glycemic control of patients with type 2 diabetes remained largely
undeter- mined (1). Because this issue had not been clearly resolved, both ... Cited by 35 - Related articles - BL Direct - All 2 versions
M Hanefeld, S Fischer, U Julius, J Schulze, … - Diabetologia, 1996 - Springer Non-insulin-dependent diabetes mellitus (NIDDM) is characterized by an excessive
incidence of myocar- dial infarction (MI) [1–3] and a shortening of life-ex-
pectancy by 5–10 years [4, 5]. There is a large amount of epidemiological ... Cited by 613 - Related articles - BL Direct - All 4 versions
MC Riddle, J Rosenstock, J Gerich - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In a randomized, open-label, parallel, 24-week
multicenter trial, 756 overweight men and women with inadequate glycemic control
(HbA 1c >7.5%) on one or two oral agents continued prestudy oral agents and ... Cited by 425 - Related articles - BL Direct - All 6 versions
AJ Garber, J Wahlen, T Wahl, P Bressler, R … - Diabetes Obesity and Metabolism, 2006 - epgonline.com Methods: Enrolled patients (n ¼ 100, HbA1c !7.5 and 10%) were !18 years of age,
had diabetes !12 months and had received a stable antidiabetic regimen for at
least 3 months [minimum of two oral antidiabetic drugs (OADs) or at least ... Cited by 141 - Related articles - View as HTML - BL Direct - All 10 versions
A Avignon, A Radauceanu, L Monnier - Diabetes care, 1997 - Am Diabetes Assoc OBJECTIVE: To evaluate the relative value of plasma glucose (PG) at different
time points in assessing glucose control of type 2 diabetic patients. RESEARCH
DESIGN AND METHODS: Glycemic profiles, ie, PG at prebreakfast (8:00 AM), ... Cited by 285 - Related articles - BL Direct - All 7 versions
- Free from Publisher EJ Bastyr, CA Stuart, RG Brodows, S Schwartz … - Diabetes Care, 2000 - Am Diabetes Assoc R esponse to diet and oral sulfonylurea agents in the treatment of type 2 dia-
betes is variable and often short-lived, with 5–10% of patients becoming
nonre- sponsive each year (1). Multiple treatment options are available at ... Cited by 222 - Related articles - BL Direct - All 6 versions
- Free from Publisher L Monnier, C Colette, GJ Dunseath, DR … - Diabetes Care, 2007 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS— In 130 type 2 diabetic patients, 24-h glucose
profiles were obtained using a continuous glucose monitoring system. The
individuals with type 2 diabetes were divided into five groups according to ... Cited by 83 - Related articles - BL Direct - All 5 versions
[CITATION] Insulin Glargine 4002 Study Investigators. The treat-to-target trial: randomized addition of …
